Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2020 | Current CAR-T clinical trials in China

Peihua Lu • 14 Dec 2020
ASH 2020
General

Peihua Lu, MD, Beijing Lu Daopei Institute of Hematology, Beijing, China, shares the current research being carried out at the Beijing Lu Daopei hospital. They are a very active clinical trials center, focusing on trialing CAR-T cellular therapies in acute lymphoblastic leukemia, multiple myeloma and lymphoma. Data from numerous CAR-T trials will be presented at ASH 2020. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020

More from Peihua Lu

1:15
AlloSCT outcomes in patients who achieve CR with CAR-T versus chemotherapy in T-ALL/LBL
Peihua Lu • 9 Dec 2023
0:53
Anti-CD7 CAR-T therapy for T-ALL/LBL
Peihua Lu • 9 Dec 2023
3:16
CD-7 targeted CAR-T therapy in heavily pretreated patients with AML: a Phase I trial
Peihua Lu • 9 Dec 2023
2:16
Evaluating the safety and efficacy of novel anti-CD7 universal CAR-T therapy in R/R T-ALL and T-LBL
Peihua Lu • 12 Dec 2022

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals